1.1Electrical support for ventricular contraction
A pulse generator delivers timed pulses through right and left ventricular leads. The programmed delay between the pulses coordinates ventricular activation in hearts with delayed conduction.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A pulse generator delivers timed pulses through right and left ventricular leads. The programmed delay between the pulses coordinates ventricular activation in hearts with delayed conduction.
A ventricular pressure transducer feeds a slope detector that signals the start of a rapid pressure rise. That signal triggers one assist stroke, and an actuator position switch ends the stroke.
A crystal oscillator schedules fixed-duration motor control updates for a continuous-flow pump. A rotor speed sensor closes the motor speed loop around a configured speed setpoint.
An arterial pressure transducer feeds a low-pass filter that estimates mean arterial pressure. The controller uses the difference between the filtered pressure and a configured pressure target to adjust assistance within preset bounds.
A position encoder reports the travel of an electromechanical actuator coupled to a ventricular support sleeve. A servo adjusts motor current to track a commanded displacement profile, with a load cell limiting peak force.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A flexible mock ventricle sits in a closed water loop with one-way inlet and outlet valves, and a motorized platen compresses its outer wall. A pressure-sensitive trigger starts each simulated heartbeat when the chamber reaches a fill threshold. A controller measures intervals between trigger events, computes the median absolute deviation of the latest eight intervals, and adjusts platen release timing to reduce variation in chamber refill time.
A reflectance photoplethysmography probe on the ear measures arterial blood volume while an external cardiac wrap applies timed compression. The controller marks each pulse at the point of maximum slope on its rising edge and timestamps successive marks to obtain pulse intervals. It computes the interquartile range of the latest intervals and uses that range to adjust wrap compression timing relative to the predicted next pulse.
A flexible restraint holds saline-filled bladders against the ventricular surface, and a reversible motor-driven piston moves fluid between the bladders and a reservoir. An electrocardiogram detector supplies beat timestamps, and the controller computes the standard deviation of a rolling set of completed intervals. A lookup table maps the measured deviation to a piston stroke and onset delay, and a pressure transducer provides feedback for limiting bladder pressure during each stroke.
An electrocardiogram detector timestamps ventricular activations, and a controller retains rolling windows of four and sixteen completed intervals. The controller computes the median absolute deviation of each window and gives the four-interval estimate greater weight when its deviation exceeds twice the sixteen-interval estimate. A calibrated lookup table maps the weighted deviation to a compression onset delay, with each update limited to a change of 10 milliseconds per beat.
An implantable pacemaker supplies timestamped ventricular sensing and pacing events to the assist controller through a dedicated telemetry link. The controller builds an interval series from sensed ventricular activations and paced activations with confirmed capture. It estimates interval dispersion and selects a delay from each confirmed activation to the start of mechanical compression using a timing table indexed by dispersion.
A controller records beat intervals, compression onset delays, and measured actuator force for each assisted cycle. A regression model fitted to the recorded cycles predicts the next interval for each of several permitted onset delays using recent intervals and force measurements as inputs. At each detected beat, the controller selects the delay whose predicted interval lies closest to the rolling median and commands the actuator at that delay.
A flexible sleeve positions inflatable chambers against the ventricular surface. A regulated gas supply fills the chambers through solenoid valves to compress the heart during an assist pulse, and exhaust valves release the pressure between pulses.
Bipolar ventricular electrodes feed a differential amplifier and an R-wave detector. A controller timestamps each accepted detection and subtracts successive timestamps to produce a series of cycle intervals.
The processor divides each cycle interval by the immediately preceding interval. It computes the median absolute deviation of the eight most recent ratios from 1.0, with zero indicating equal intervals across that window.
A controller compares the latest cycle interval with the median of the preceding eight intervals. It uses the signed difference to advance or retard the next pneumatic compression pulse within a preset timing window, using subsequent interval measurements as feedback toward a ratio of 1.0.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Accordingly, host system 302 may include one or more stimulus elements (e.g., electrical and/or mechanical stimulus elements) adapted to be implanted within a patient.A · US 2008/0300641 A1 · ¶ 32
Cardiac function values may include, for example, values describing heart rate, heart rate variability, atrial/ventricle synchronicity, atrial rhythm, and/or ventricle rhythm. In an embodiment, the cardiac function values may include values specifically related to heart rate variability including, but not limited to, any one or more values selected from a group of values that includes RR interval, SDNN, SDANN, rMSSD, pNN50, HF (ms2 and/or NU), Ln HF, LF (ms2 and/or NU), Ln LF, and/or LF/HF.A · US 2008/0300641 A1 · ¶ 41
In an embodiment, the cardiac function values may include values specifically related to heart rate variability including, but not limited to, any one or more values selected from a group of values that includes RR interval, SDNN, SDANN, rMSSD, pNN50, HF (ms2 and/or NU), Ln HF, LF (ms2 and/or NU), Ln LF, and/or LF/HF.A · US 2008/0300641 A1 · ¶ 41
Beat validation to reduce artifacts Characterization of pulseoximetric waveform, by morphological analysis of the ascendent and descendent tracts of a single pulse Removal of beat intervals with values lower than 0.3 s and longer than 1.5 s Estimation of quantitative indexes Coefficient of variation of the first differences of beat-to-beat interval series Shannon entropy of the beat-to-beat interval series Classification of the heart rhythm: Estimation of the Mahalanobis distB · US 2013/0102864 A1 · ¶ 29
For example, response generating element 416 may initiate cardiac stimulus element 418 to generate a stimulus to the heart tissue (e.g., defibrillation stimulus, pacing stimulus, pacing rate adjustment, pacing characteristic adjustment, and/or pulse adjustment stimulus).A · US 2008/0300641 A1 · ¶ 52
An empty cell means only that no passage was reproduced there.
For example, patients may not be diligent or accurate in recording information regarding physical activity or stress levels, and patient-recorded times may not be accurately synchronized with ECG time marker information.A · US 2008/0300641 A1 · ¶ 7
For at least the foregoing reasons, a need exists for systems, apparatus, and methods adapted to accurately collect and correlate cardiac data and physical activity information to facilitate accurate diagnosis of the causes behind recurring arrhythmias or other cardiac anomalies and to facilitate determination of effective treatment strategies.A · US 2008/0300641 A1 · ¶ 7
Such classification is implemented directly in the device, suitable for at home use, and the result of the classification is displayed automatically using a three-state, traffic-light indicator.B · US 2013/0102864 A1 · ¶ 1
Therefore, monitoring of AF episodes based on only symptomatic events will adversely affect the reliability of identifying patients with AF.B · US 2013/0102864 A1 · ¶ 10
patent.fyi, US 2026/0355500 A1, claim 1, first published 2026-11-19T12:21:55-05:00, https://patent.fyi/US20260355500/, SHA-256 f68ef25b0ea9a32f582831d4dbd98ff7968e3c6d880a1c13749e5254b7e6e53c